A multi-institutional, prospective study of incorporating the genomic platform breast cancer index as a tool for decision-making regarding extension of adjuvant endocrine therapy

dc.authorid0000-0001-8080-7960
dc.contributor.authorSanft, T.
dc.contributor.authorBerkowitz, A.
dc.contributor.authorSchroeder, B.
dc.contributor.authorHatzis, C.
dc.contributor.authorSchnabel, C.
dc.contributor.authorAktas, B.
dc.contributor.authorBrufsky, A.
dc.date.accessioned2025-05-10T19:41:05Z
dc.date.issued2017
dc.departmentİstanbul Medeniyet Üniversitesi
dc.descriptionSan Antonio Breast Cancer Symposium -- DEC 06-10, 2016 -- San Antonio, TX
dc.description.abstract[No abstract available]
dc.identifier.doi10.1158/1538-7445.SABCS16-P2-09-15
dc.identifier.issn0008-5472
dc.identifier.issn1538-7445
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1158/1538-7445.SABCS16-P2-09-15
dc.identifier.urihttps://hdl.handle.net/20.500.14730/10186
dc.identifier.volume77
dc.identifier.wosWOS:000397999001048
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherAmer Assoc Cancer Research
dc.relation.ispartofCancer Research
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleA multi-institutional, prospective study of incorporating the genomic platform breast cancer index as a tool for decision-making regarding extension of adjuvant endocrine therapy
dc.typeConference Object

Dosyalar